BDX Today - Aug 05: Slight Dip Amid Mixed News
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what went down? The stock was kind of chillin’ around the same spot, barely moving, but it did get smoked a little, closing at $169.13. The volume was average, nothing crazy. It’s like the market was just taking a breather today.
Now, why the dip? Well, there are a couple of things at play. First off, there was some buzz about their upcoming earnings. They’re expected to drop earnings of about $3.14 a share, which sounds solid, but maybe investors are feeling a bit cautious. You know how it goes — when earnings are looming, people get jittery. Plus, there’s chatter about Becton Dickinson’s partnership in Brazil around Semaglutide. Some folks think that could fuel growth, but there’s always that “is it too good to be true?” vibe in the air.
On the flip side, competitors like Waters and West Pharmaceutical were hitting it big today. Their stocks were outperforming, which might’ve put a little pressure on BDX. It’s like, when your friends are winning, and you’re just kinda hanging back, it can sting a bit, right?
Looking ahead, it’s worth mentioning that Becton Dickinson is gearing up for their Q3 earnings report. That’s coming up soon, and investors are definitely going to have their eyes peeled for that. It could shake things up, either in a good way or a not-so-good way.
So, to wrap it up, BDX had a bit of a rough patch today, but with earnings on the horizon and some mixed news floating around, it’s a waiting game for now. Just remember, this is all for fun and info, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません